Human Vaccine Market to Grow at 11.69% CAGR Driven by Vaccination and Immunization Programs to 2020

Share this news:

The global human vaccine market steady growth rate is heavily influenced by the inclusion of several pediatric vaccines in the national immunization schedule of various countries. This helps in increasing the consumption of vaccines, which in turn fosters market growth during the predicted period.

A major trend being witnessed in the global human vaccine market is the increase in strategic alliances. Increase in threat from regional vendors in developing countries may cause price erosion and may compel major players to operate under low-margin models. M&A are usually intended to increase the market penetration of the acquirer or to enhance the product portfolio of the parent company.

Complete report on human vaccine market spread across 111 pages, analyzing 4 major companies and providing 82 data exhibits is now available at http://www.reportsnreports.com/reports/461270-global-human-vaccine-market-2016-2020.html.

The analysts forecast global human vaccine market to grow at a CAGR of 11.69% during the period 2016-2020. The growth of the global human vaccine market is driven by the inclusion of several pediatric vaccines in the national immunization schedule of various countries. This helps in increasing the consumption of vaccines. Similarly, the increase in the prevalence of infectious diseases and cancers is also leading to market growth.
Segmentation by Type of Human Vaccine and Analysis of the Human Vaccine Market - Preventable human vaccines and Therapeutic human vaccines

The preventable human vaccine segment currently accounted for more than 94% of the total market share and is envisaged to grow at an impressive CAGR of more than 10% during the forecast period. Factors such as the inclusion of pediatric vaccinations in the national immunization programs (NIPs) of various countries, public-private initiatives, and the growing focus on the emerging countries will propel market growth in this segment during the estimated period.

Order a copy of Global Human Vaccine Market 2016-2020 report @ http://www.reportsnreports.com/Purchase.aspx?name=461270.

Geographical Segmentation of the Human Vaccine Market
In this market research, analysts have envisaged the Americas to be the largest market for human vaccines during the forecast period. High incidences of infectious diseases and cancers in regions like the US, Canada, and Latin America is a significant factor, which will result in this region’s impressive market share of nearly 45% by 2020.

The global human vaccine market is highly competitive owing to the presence of numerous small and large players that operate on a local or global scale. The vendors in this market compete on the basis of price, quality, and innovation to gain maximum market prominence during the forecast period. The intense level of competition in this market has led an increased number of M&A, wherein smaller entities are being acquired by, or are being merged with, major players.

The key vendors analyzed in human vaccine market are GlaxoSmithKline, Merck, Pfizer, and Sanofi.
Other prominent vendors in the market include, Abbott, AstraZeneca, Bavarian Nordic, Baxter, Bharat Biotech, Bharat Immunologicals and Biologicals , bioCSL, Bio Med, Crucell, Dynavax Technologies, Indian Immunologicals, Janssen Pharmaceuticals, Kaketsuken, LG Life Sciences, Mitsubishi Tanabe Pharma, Lupin, Nuron, Novartis, Protein Sciences Corporation, Panacea Biotec, Roche, Serum Institute of India, Shenzhen Kangtai Biological Products, Sinovac Biotech, S K Chemicals, Takeda Pharmaceutical, Valeant Pharmaceuticals, and Zydus Cadila.

Further, the human vaccine market report states that inadequate vaccination coverage is impeding the growth of the market.

Another related report is Global Travel Vaccines Market 2015-2019, analysts forecast the global travel vaccines market to grow at a CAGR of 7.78% over the period 2014-2019. One major trend upcoming in this market is the public-private initiatives undertaken in developing countries for scheduling and supplying vaccines to the target population. Organizations such as the GAVI, the WHO, and UNICEF have developed partnerships with governments and are involved in providing vaccines to remove the misconceptions about vaccination and immunization. Browse complete report @ http://www.reportsnreports.com/reports/345352-global-travel-vaccines-market-2015-2019.html.

Key players in the global travel vaccines market: GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG and Sanofi
Other prominent vendors in the market are: Beijing Minhai Biotechnology, Bharat Biotech, Bio Med, Crucell, CSL, Dynavax Technologies, Emergent Biosolutions, Green Signal Bio Pharma, Hualan Biological Engineering, Imunoloski Zavod, Indian Immunologicals, Janssen Pharmaceuticals, JN International Medical, Kaketsuken, LG Life Sciences, Novavax, Nuron Biotech, Panacea Biotec, Pfizer, Shenzhen Kangtai Biological Products, Serum Institute of India, Sinovac Biotech, S K Chemicals, Vacunas Finlay and Valneva

About Us:
ReportsnReports.com is single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, helps in purchase decision by mapping the information needs with the huge collection of reports.

Contact Info:
Name: Ritesh Tiwari
Email: Send Email
Organization: ReportsnReports
Address: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar, Pune, Maharashtra 411013, India.
Phone: + 1 888 391 5441
Website: http://www.reportsnreports.com/reports/461270-global-human-vaccine-market-2016-2020.html

Release ID: 103180

CONTACT ISSUER
Name: Ritesh Tiwari
Email: Send Email
Organization: ReportsnReports
Address: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar, Pune, Maharashtra 411013, India.
SUBSCRIBE FOR MORE